Trial Duration, Disease Severity Impact Discontinuation and COPD Exacerbation
An analysis of discontinuation in randomized controlled trials for chronic obstructive pulmonary disease (COPD) has determined the main factors causing patients to drop out of clinical trials. The results were published in the International Journal of COPD.
Smoking Cessation Treatments Do Not Increase Risks in Patients With COPD
Getting smokers to quit smoking sometimes requires medical intervention, such as varenicline and bupropion; however, there have been concerns about the safety of these smoking cessation treatments in smokers with chronic obstructive pulmonary disease.